Research Idea
Research content for general circulation. Not individualized advice. Methodology & Disclosures
UnitedHealth beat Q3 earnings and revenue expectations, raised full-year guidance, and reported an improved medical care ratio. Shares gained about 9.4% over 21 trading days.
Loading chart data...
AI Analyst Overview
Loading chart data...
Valuation Metrics
Fundamental Analysis
Key Financial Insights: ⢠Strong Cash Flow ⢠Improving Margins ⢠Liquidity Pressure UNH shows strong cash generation and improving margins, but weak liquidity, high intangibles, leverage, and a richer valuation warrant caution.
Price Behavior
Key Price Behavior Insights: ⢠Bearish trend ⢠Support holding ⢠Resistance overhead Support Level: $375.20â$376.00 Resistance Level: $385.90 UNH remains bearish over the last month, holding above $375.20â$376.00 support but needing a sustained break above $385.90 to improve momentum.
Sentiment & News
Key News Insights: ⢠Raised 2026 guidance ⢠Optum AI expansion ⢠Improving medical costs UnitedHealth's improving costs, stronger Optum growth, raised guidance, and AI investment support a positive recovery outlook despite mixed institutional activity.
AI Summary
UNH is now a margin-recovery execution trade rather than a dependable compounder: 2026 guidance, Medicare Advantage improvement, Optum growth and buybacks support upside, but sustained returns require proof that commercial underwriting and Medicaid losses can normalizeânot merely short-term medical-cost reliefâmaking margin evidence the key buy/hold trigger at an already fuller valuation.
Description
UnitedHealth Group is a diversified U.S. healthcare company organized into four primary businesses: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. UnitedHealthcare sells a range of health benefit plans for employers, individuals and government programs, while Optum Health operates care delivery networks and related services; Optum Insight provides data, software and consulting to healthcare organizations; and Optum Rx manages pharmacy services and prescription programs. The company provides integrated clinical, administrative and pharmacy solutions to payers, providers, employers and government clients and is headquartered in Minnetonka, Minnesota.
Idea History
| Date | Close | Ticker | Company | Summary | Status | P/L |
|---|---|---|---|---|---|---|
| Oct 15 | Oct 22 | UNH | UnitedHealth Group Incorporated | UnitedHealth beat Q3 earnings and revenue expectations, raised full-year guidance, and reported an improved medical care ratio. Shares gained about 9.4% over 21 trading days. | Active | +2.5% |
| Jul 22 | Jul 29 | UNH | UnitedHealth Group Incorporated | Q2 2026 beat and raised full-year guidance on 2026-07-16, with supportive healthcare rotation and technical strength above the 425-427 breakout area. | Closed | -2.5% |